CRINETICS PHARMACEUTICALS
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
CRINETICS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.crinetics.com
Total Employee:
101+
Status:
Active
Contact:
(760) 274-6963
Total Funding:
446 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Crinetics Pharmaceuticals
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Crinetics Pharmaceuticals
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Crinetics Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Crinetics Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Crinetics Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Crinetics Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Crinetics Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series B - Crinetics Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Crinetics Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Crinetics Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.crinetics.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.51 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
